Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
2.500
0.00 (0.00%)
At close: Sep 5, 2025, 4:00 PM
2.518
+0.018 (0.73%)
Pre-market: Sep 8, 2025, 8:52 AM EDT
Cronos Group Market Cap
Cronos Group has a market cap or net worth of $963.40 million as of September 8, 2025. Its market cap has increased by 6.78% in one year.
Market Cap
963.40M
Enterprise Value
189.91M
1-Year Change
6.78%
Ranking
Category
Stock Price
$2.50
Market Cap Chart
Since February 27, 2018, Cronos Group's market cap has decreased from $1.14B to $963.40M, a decrease of -15.35%. That is a compound annual growth rate of -2.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 957.30M | 23.97% |
| Dec 31, 2024 | 772.20M | -3.05% |
| Dec 29, 2023 | 796.50M | -17.14% |
| Dec 30, 2022 | 961.30M | -34.04% |
| Dec 31, 2021 | 1.46B | -41.04% |
| Dec 31, 2020 | 2.47B | -6.25% |
| Dec 31, 2019 | 2.64B | 42.01% |
| Dec 31, 2018 | 1.86B | 63.14% |
| Feb 27, 2018 | 1.14B | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |